Stifel Reiterates Hold Rating on ResMed (RMD), but Raises Estimates
Tweet Send to a Friend
Stifel analyst Jonathan Block reiterated a Hold rating and $265.00 price target on ResMed (NYSE: RMD).The analyst commented, "Our proprietary ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
